Meeting
2018 Genitourinary Cancers Symposium
Outcomes of serial MRI/ultrasound fusion targeted biopsy in men with very low-risk and low-risk prostate cancer managed with active surveillance.
Authors
Walter Hsiang
Yale School of Medicine, New Haven, CT
Walter Hsiang , Kamyar Ghabili , Jamil Syed , Kevin Nguyen , Alfredo Suarez-Sarmiento , Michael Leapman , Preston Sprenkle
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 114)
DOI
10.1200/JCO.2018.36.6_suppl.114
Abstract #
114
Poster Bd #
F12
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Increasing utilization of multi-parametric magnetic resonance imaging in prostate cancer active surveillance.
First Author: Avinash Maganty
Poster
2017 ASCO Annual Meeting
The accuracy of multiparametric magnetic resonance imaging (mpMRI) using PI-RADS v2 in disease upgrading on re-biopsy among patients with low-risk prostate cancer (PCa) on active surveillance (AS): A Brazilian perspective.
First Author: Públio C. C. Viana
Poster
2013 Genitourinary Cancers Symposium
Multidisciplinary care and management of very low-risk prostate cancer.
First Author: Ayal A. Aizer
Poster
2024 ASCO Genitourinary Cancers Symposium
The Capio Prostate Cancer Center model for prostate cancer diagnostics using Stockholm3, MRI, and targeted biopsies: Real-world evidence from 2018 to 2022.
First Author: Thorgerdur Palsdottir